Unaudited Condensed Consolidated Statements of Stockholders’ Equity - USD ($)	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total
Balance at Dec. 31, 2022	$ 1,448	$ 120,105,728	$ (139,295)	$ (97,088,422)	$ 22,879,459
Balance (in Shares) at Dec. 31, 2022	1,447,722
Stock-based compensation		751,821			751,821
Costs related to ATM		(17,920)			(17,920)
Foreign currency translation adjustment			(18,669)		(18,669)
Net loss				(7,051,367)	(7,051,367)
Balance at Mar. 31, 2023	$ 1,448	120,839,629	(157,964)	(104,139,789)	16,543,324
Balance (in Shares) at Mar. 31, 2023	1,447,722
Balance at Dec. 31, 2023	$ 2,370	128,044,509	(148,192)	(118,331,653)	9,567,034
Balance (in Shares) at Dec. 31, 2023	2,370,000
Sales of common stock through the at-the-market offering	$ 2	12,582			12,584
Sales of common stock through the at-the-market offering (in Shares)	1,720
Sale of common stock and warrants through direct offering, net of offering costs	$ 147	903,408			903,555
Sale of common stock and warrants through direct offering, net of offering costs (in Shares)	147,500
Stock-based compensation		626,990			626,990
Costs related to ATM		(15,000)			(15,000)
Foreign currency translation adjustment			(55,595)		(55,595)
Net loss				(5,735,144)	(5,735,144)
Balance at Mar. 31, 2024	$ 2,519	$ 129,572,489	$ (203,787)	$ (124,066,797)	$ 5,304,424
Balance (in Shares) at Mar. 31, 2024	2,519,220